The University of Manchester has been awarded more than £5m for research into using nanomaterials including graphene in the human body.
The £5.2m grant was provided by the Engineering and Physical Sciences Research Council (EPSRC) for the project titled: ‘2D Materials for Next Generation Healthcare Technologies’ (2D-Health) that aims to further explore how two-dimensional materials can improve major health challenges, such as cancer, diabetes and dementia.
The announcement was made today by Jo Johnson MP, Minister of State for Universities and Science, as part of £17.7m for new healthcare technologies research to address the health issues of an aging UK population.
The University of Manchester is home to the Nanomedicine Lab, which brings together bioengineering, pharmacology and nanotechnology and their translation to advanced, clinically-relevant therapeutics and diagnostics.
Potential areas of benefit using graphene and other 2D materials could include targeted drug delivery systems to attack cancer cells while leaving other cells unharmed, remote electrical stimulation of nerves affected by neurodegenerative and other diseases, such as diabetes or smart dressings for burns and wounds to allow faster healing and minimise damage to tissue.
Professor Kostarelos said: “We are delighted both with the decision by the EPSRC to fund our ambitious research programme and the pharmaceutical industry support that has enthusiastically embraced 2D material technologies as particularly promising.
Read More
No comments:
Post a Comment